Skip to main content
Uncategorized

Brain diseases: new perspectives from the “2005 Marató”

By 30 de June de 2011November 18th, 2020No Comments
< Back to news
 30.06.2011

Brain diseases: new perspectives from the “2005 Marató”

The latest findings on neurodegenerative diseases revealed in the 35 projects funded by "2005 La Marató", including two projects coordinated by researchers at IRB Barcelona, were presented yesterday during the 12th Symposium of the "Fundació La Marató de TV3".


The social impact of neurodegenerative diseases spurred the “La Marató de TV3” to dedicate the 7.72 million euros raised during its 2005 campaign to 35 research projects dedicated to Parkinson’s, vascular diseases of the brain, Alzheimer’s, epilepsy, and other neurological disorders. Among these projects, two were coordinated by researchers at IRB Barcelona.

Joan Guinovart, director and group leader at IRB Barcelona, has developed the project “Molecular basis of progressive myoclonus epilepsy of the Lafora type”, devoted to the identification of the molecular and cellular processes that are altered during the progression of this rare and devastating disorder.

Ernest Giralt, coordinator of the Chemistry and Molecular Pharmacology Programme at the same institute, has coordinated the project “Structural and dynamic characterization of Aß aggregation. Examination of Aß aggregation peptide inhibitors”, within basic studies linked to the Aß aggregation processes that characterize Alzheimer’s disease.

The symposium included the second edition of the awards “Divulga la Recerca de la Marató”, organized by the “Fundació Marató de TV3” and the “Fundació Institució Catalana de Suport de la Recerca”. Thirty-three short films produced entirely by visual-media communication students participated in this competition, which aimed to explain the results of the Marató-funded research to general public. Two of these videos focused on Ernest Giralt’s work on the structural biology of Aß aggregates and Joan Guinovart’s insights into the molecular basis of the Lafora disease.

More information